Metronidazole → HCID 70170973, compound
Reaction equation
[CH3:1][CH2:2][N:3]1[C:9]2[N:10]=[C:11]([CH3:14])[CH:12]=[CH:13][C:8]=2[C:6](=[O:7])[C:5]([C:15]([OH:17])=[O:16])=[CH:4]1.[CH3:18][C:19]1[N:23](CCO)[C:22]([N+:27]([O-:29])=[O:28])=[CH:21][N:20]=1.[CH3:30][CH2:31]N=C=NCCCN(C)C>CN(C1C=CN=CC=1)C.C1COCC1>[CH3:18][C:19]1[NH:23][C:22]([N+:27]([O-:29])=[O:28])=[CH:21][N:20]=1.[CH2:2]([N:3]1[C:9]2[C:8](=[CH:13][CH:12]=[C:11]([CH3:14])[N:10]=2)[C:6](=[O:7])[C:5]([C:15]([O:17][CH2:30][CH3:31])=[O:16])=[CH:4]1)[CH3:1]Participants
6
Procedure
The reaction mixture of nalidixic acid (232 mg, 1.0 mmol), metronidazole (171 mg, 1.0 mmol), EDCI (230 mg, 1.2 mmol), DMAP (20 mg, 0.2 mmol) and THF (5 ml) was stirred at room temperature for 24 h. THF was then removed under reduced pressure. The residue was dissolved in dichloromethane (50 ml). The organic layer was washed with H2O, 5% Na2CO3, H2O, and brine, and then dried over MgSO4. The solvent was removed under vacuum. The resulting solid was recrystallized from C2H5OH and ethyl acetate to give 56 mg 2-methyl-5-nitro-1H-imidazole-1-ethyl 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate. m.p.: 122-124° C.
Workup
- customTHF was then removed under reduced pressure
- dissolutionThe residue was dissolved in dichloromethane (50 ml)
- washThe organic layer was washed with H2O, 5% Na2CO3, H2O, and brine
- dry with materialdried over MgSO4
- customThe solvent was removed under vacuum
- customThe resulting solid was recrystallized from C2H5OH and ethyl acetate
Sources & evidence
- ORD record
- ord-e9392f5f31af43568c1513ead2104e52
- Source dataset
- uspto-grants-2002_07
- Patent number
- US06423707B1
Reaction notes
Loading…